News

Infectious Disease Advisor10h
Ready-To-Use, Low IgA Gammagard Liquid ERC Approved for Primary Immunodeficiency
The FDA has approved Gammagard Liquid ERC as a replacement therapy for PI in adult and pediatric patients 2 years of age and older.
Dermatology Advisor10h
Benlysta Autoinjector Approved for Pediatric Patients with Lupus Nephritis
The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.
Cancer Therapy Advisor21h
Zegfrovy Granted Accelerated Approval for NSCLC With Exon 20 Insertions
The US Food and Drug Administration (FDA) has granted accelerated approval to Zegfrovy (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC ...
Clinical Advisor10h
FDA Greenlights Oral Therapy for NSCLC With EGFR Exon20 Insertion Mutations
In a primary efficacy population of 85 patients, the confirmed overall response rate was 46%.